The deposition of platelets on subendothelium of rabbit aortic segments exposed to non-anticoagulated human blood increased progressively with increasing wall shear rates (50-2,600 s-'), whereas fibrin deposition decreased. Studies in normal subjects and patients with platelet disorders suggested that, under the conditions used, platelets were essential for fibrin deposition at intermediate (650 s-') but not low (50 s-1) shear rates. Fibrin deposition was markedly diminished in a patient with Scott syndrome whose platelets have a diminished capacity to bind Factor X. and activate Factors IX and II. In glycoprotein IIb-IIIa deficiency, fibrin deposition was normal (or somewhat increased), whereas in glycoprotein lb deficiency the association of fibrin with platelets, but not subendothelium, was decreased. The findings indicate that platelets, perhaps through surface localization of coagulation proteins, promote fibrin deposition on subendothelium at arterial shear rates and suggest that agents directed against platelet coagulant properties could be antithrombotic.
Introduction
The properties of platelets that permit them to adhere and aggregate at sites of blood vessel injury account, in part, for their role in the primary arrest ofbleeding, and explain the prolonged bleeding time in patients with disorders of platelet adhesion/ aggregation (cohesion) such as von Willebrand's disease and thrombasthenia (1) (2) (3) . These properties ofadhesion and cohesion also contribute to the formation of occlusive platelet thrombi in arteries where local shear conditions, through convective and diffusion mechanisms, favor the deposition of platelets on the vessel wall (4, 5) . Extensive laboratory studies, generally performed in test tubes under poorly defined shear conditions (probably low), have also established that platelets provide a surface which can greatly accelerate the coagulation mechanism (6) (7) (8) and, hence, could play an important role in the permanent arrest ofbleeding. Platelets could also contribute to the formation ofthe fibrin component ofintravascular thrombi, but the extent to which the coagulant properties ofplatelets may be influenced by flow conditions in various parts ofthe circulatory system has Dr. Turitto's present address is Department ofMedicine, Mt. Sinai Medical School, New York 10029.
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not been studied. It is generally held, for example, that platelets play a relatively minor role in the development of thrombi in large veins (shear rate of 100 s51 or less) because fibrin and red cells account for most ofthe mass ofsuch thrombi (9, 10) . However, the nidus of a venous thrombus may contain a small but significant number of platelets (1 -13) which could, in theory, accelerate the formation of fibrin, even though they do not account for the bulk of the thrombus (14) . Whether or not this small mass ofplatelets is ofany significance in the initiation and extension of a venous thrombus is still an open question (10) . Even where platelets clearly contribute to the mass of a mixed platelet-fibrin thrombus, as in the major epicardial coronary vessels (15, 16) , (shear rates 200-800 s-' [17] ), it is not clear to what extent the potential platelet coagulant activity is actually utilized in fibrin formation. Finally, and almost paradoxically, the increasing contribution ofplatelets to a thrombotic mass, or a primary hemostatic plug, at even higher shear rates (2,000 s-', or more), such as those found in arterioles (17) , is generally associated with a decrease in fibrin formation (2, 18) .
This study was undertaken to evaluate the procoagulant properties of platelets on vascular surfaces throughout a wide range of shear rates. Utilizing an annular perfusion chamber, we exposed everted segments of rabbit aorta, from which the endothelium has been removed by balloon catheter, to human blood at shear rates ranging from 50-2,600 s-1 and measured the deposition of platelets and fibrin on the subendothelium, and the blood fibrinopeptide A levels in postchamber blood. We studied normal and thrombocytopenic subjects to establish the flow conditions at which platelets contribute to fibrin formation, and utilized patients with well-characterized platelet defects to identify platelet properties which may contribute to this process.
Methods

Perfusion chamber containing vessel segments
The perfusion chamber is an annular device on the core of which is mounted an everted segment of rabbit aorta whose endothelium has been completely removed by balloon catheter (19) (20) (21) (22) . Chambers oftwo different sizes, designated original and small (20) , were used in the study. Non-anticoagulated blood entering the chamber passes through the annular space formed by the subendothelial surface and the outer cylinder wall, thereby permitting fibrin and platelet deposition on the exposed subendothelial surface. The flow parameters, dimensions, and temperature (37'C) control for the chamber have been previously described 
Perfusion procedure
The basic technique for exposing everted vessel segments to non-anticoagulated blood at varying shear rates, and for obtaining pre-and postchamber samples for fibrinopeptide A levels (24), has been described in detail previously (20, (24) (25) (26) . Basically, blood is drawn directly from the antecubital vein through an infusion set (Butterfly, Abbott Laboratories, Irving, TX) into the perfusion chamber and is not recirculated (24) (25) (26) (27) . Flow rate is controlled by a Holter roller pump (Extracorporeal Medical Specialties, Inc., King of Prussia, PA) placed distal to the perfusion chamber and is accurately determined during each run by measuring the actual amount of blood collected at 30-s intervals (21, 24) . The perfusion is terminated by stopping the pump, and blood proximal and distal to the perfusion chamber (designated prechamber and postchamber blood) is collected for measurement of fibrinopeptide A (FPA)' (24) as follows: proximal to the chamber the infusion tubing used for the venipuncture is clamped with two hemostats and severed with scissors. Blood (0.2 ml) from the venipuncture site is collected through the tubing by gravity into a predetermined volume (1.8 ml) of inhibitor solution (24) . Distal to the chamber, the silastic tubing that connects the perfusion chamber to the pump is removed and the blood (0.2 ml) contained within is drained into inhibitor solution (1.8 ml). The period of time required to sample blood for FPA measurements, during which blood remained in contact with the vessel segment under zero flow conditions, is recorded and varied from 30 to 45 s. After obtaining blood samples for FPA, the distal tubing is replaced and the vessel segment is washed free of blood and fixed with glutaraldehyde as follows: the severed end of the infusion tubing that is connected to the perfusion chamber is first immersed into phosphate-buffered saline (0.02 M phosphate, 0.1 M NaCl, pH 7.4), and the pump flow is reinitiated at the original flow rate for variable periods oftime (see below) to wash out the blood in the chamber. The pump is then stopped, the infusion tubing is switched to 2.5% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.2, and the flow is restarted to fix the segment on the chamber rod. Wash and fixation times of the perfusion system were adjusted for the various flow conditions and approximated a constant volume of fluid (7-10 ml) passing through the chamber. At a shear rate of 2,600 s-', washout times were 5 and 10 s with buffer and fixative respectively; at 1,300 s51, 5 and 15 s; at 650 s-', 10 and 30 s; at 100 s5l, 15 and 15 s; and at 50 s5l, 30 and 30 s. The perfusion rod with vessel attached was then removed from the chamber and immersed in buffered glutaraldehyde solution (as above) for up to 1 h, then transferred to 7% sucrose solution, and kept at 4VC until embedded in epoxy.
Evaluation ofvessel segments
After perfusion, vessel segments were embedded in epoxy resin in an oriented manner. Vessel cross-sections, -0.8 um in thickness, were stained and evaluated morphometrically by light microscopy for platelet interactions and fibrin deposition (19) (20) (21) 24 ). All evaluations were by technologists who were unaware of the sources of the material. For each vessel segment, one section, located 10-13 mm distally from the proximal end ofthe vessel segment, was evaluated for platelet and fibrin deposition.
Fibrin (presence or absence) on the subendothelium (FSE) and on platelets (Fph) was evaluated systematically at 10-um intervals (-1,000 intersections) and total fibrin (FT = FSE + FO) expressed as a percentage of the total number of evaluations (20, (24) (25) (26) (3, 31) were studied. Previous studies on these patients have demonstrated absent platelet aggregation with ristocetin (21), impaired platelet adhesion to subendothelium in citrated blood (shear rates 800 [21] and 1,300 [20] s-') and non-anticoagulated blood (1,300 s-') (20) , and decreased amounts of platelet GPIb (33).
Thrombocytopenia. Ten patients (seven females and three males) with either drug-induced thrombocytopenia (three patients) or idiopathic thrombocytopenic purpura (seven patients) were studied. The hemoglobin level, white blood cell count, prothrombin time, and partial thromboplastin time were normal in each patient. No evidence for an underlying disease which might have accounted for isolated thrombocytopenia was found in any of these patients.
Normal subjects. Control values were obtained by studying normal hospital personnel, ages 25-50. Blood values Platelets were counted on blood collected into EDTA by an electronic counting device (model S, Coulter Electronics, Inc., Hialeah, FL) or by phase microscopy. The average values and ranges for platelet counts (per microliter) in patients and normal subjects were as follows: thrombasthenia (n = 3), studied once at 650 s-', 224,000 (162,000-328,000);
Bernard-Soulier syndrome (n = 2), studied once at 50 and 1,300 s-', and twice at 650 s-', 91,000 and 115,000; Scott syndrome, studied at 50 (n = 2), 100 (n = 1), 650 (n = 5), and 1,300 (n = 2) s-', 367,000 (range 304,000-403,000); thrombocytopenia (n = 10), 24,000 (1,000-68,000). A total of 36 normal subjects (14 males and 22 females) were studied, some on several occasions, at shear rates ranging from 50 to 2,600 s-'. The average platelet count was 288,000 (201,000-370,000).
Normal subjects with platelet counts > 370,000/,l were excluded from the study.
Results
Effect ofshear rate on platelet and fibrin deposition on subendothelium in normal subjects
The everted de-endothelialized vessel segment was exposed to directly sampled (non-anticoagulated) venous blood from normal subjects for 5 min at shear rates of 50, 100, 650, 1,300, and 2,600 s-'. After perfusion, a postchamber blood sample was obtained for determination of FPA and the vessel segments were removed for evaluation of platelet and fibrin deposition. Fig. 1 A shows the relationship between subendothelial coverage with adherent platelets (C + S) and fibrin deposition on the subendothelium (FSE) and Fig. 1 B shows the dimensions ofthe platelet thrombi. At the lowest shear rate (50 s-'), only 5.3±0.5% of the vessel surface was covered with adherent (C + S) platelets (Fig.  1 A) . With increasing shear rate, platelet adhesion, as well as thrombus volume and average maximum thrombus height ( Fig.  1 B) , also increased. The average maximum height, for example, increased from 36±8 gm at 50 s-' to 130±22 jtm at 2,600 s-'.
Thus, the effect of increasing shear rate was to enhance both the attachment (C + S) of platelets to the surface as well as the size of the platelet thrombi that formed over adherent platelets. The opposite was true for fibrin deposition on the subendothelium, which was maximum (FSE = 85.3±3.1% surface coverage) at 50 s-', and decreased sharply at shear rates > 650 s-'. The latter was also the case for blood FPA levels, shown in Fig. 2 63,000/pul. The range of values for fibrin deposition in these patients was 3.4 to 99.3%. Fibrin deposition was clearly related (r = 0.67, P < 0.05) to surface coverage with platelets adherent to the subendothelium (Fig. 3 B) . (Not surprisingly, the surface coverage with platelets also correlated [r = 0.80, P < 0.01] with the number of platelets in the blood, Fig. 3 A. ) Thus, the lowest values for fibrin deposition (3.4 to 19.6%) were in four patients whose adhesion (C + S) values were <4%, whereas adhesion values > 4% in the six other patients were associated with fibrin deposition values thatwere, with one exception, >79% (one value was 40.5%). These findings suggest that platelets are necessary to support normal levels offibrin deposition on subendothelium at a shear rate of650 s-', and that only a relatively small number are required. Interestingly, although fibrin deposition on the Fig. 4 is a photomicrograph showing representative findings in this patient (Fig.  4 B) . The data for all parameters of coagulation and fibrin on subendothelium are shown in Table II . Platelet adhesion (C + S) values in this patient were normal and, in fact, were slightly increased. Despite the normal values of platelet adhesion, total fibrin deposition (Fig. 4 B Thrombasthenia. Thrombasthenic platelets adhered normally as a monolayer on the subendothelium. Platelet-to-platelet interaction was absent (Table II) at this shear rate, as has been observed previously at all other shear rates studied (38) , demonstrating the complete lack of platelet-to-platelet cohesion in patients whose platelets are deficient in GPIIb-IIIa. In striking constrast to the patient with Scott syndrome, all parameters of fibrin deposition (total, subendothelial, and platelets) were normal and, in fact, were somewhat increased (Table II and Bernard-Soulier syndrome. As shown in Table II, platelet adhesion values (C + S) in two patients with the Bernard-Soulier syndrome were decreased to a level (12%) that was similar to values (12±4%) in the group ofthrombocytopenic patients with normal fibrin deposition. However, a moderate decrease (FT = 50%) in total surface coverage with fibrin was observed and was almost entirely due to a decreased value (3%) of Fph. The Studies performed at a shear rate of650 s-' and a perfusion time of10 min * In addition to the 5-min perfusion studies described above, * studies utilizing a perfusion time of 10 min were also performed on most patients (two ofthe 10 thrombocytopenic patients were not studied at this condition). The results, shown in Table III fibrin deposition on the surface (11%) was markedly decreased. Finally, the platelet thrombus height was less (>2 SD) than control values in Scott syndrome, probably owing to impaired thrombin generation, as previously observed in hemophilic patients at this shear rate (24 At this low shear condition, fibrin deposition (88.7%, Fig. 5 ) and FPA levels (706 ng/ml) were normal in a patient with severe thrombocytopenia (1,000/,gl), despite the absence of detectable 461 ng/ml) and in a patient with the Bernard-Soulier syndrome (82% and 408 ng/ml). Thus, at the shear rate of 50 s-' fibrin deposition approached surface saturation despite low (0-6.5%) values of platelet deposition in both normal subjects and in patients with platelet defects in whom impaired fibrin formation is observed at the higher shear rate of 650 s-'. These observations on patients, as well as the findings in normal subjects, indicate that fibrin deposition is strongly dependent on the shear rate. In addition, the patient studies at 650 s-', as well as the continued abnormality of fibrin deposition in Scott syndrome and the Bernard-Soulier syndrome at 1,300 s-' (Fig. 5) , demonstrate that platelets contribute to fibrin deposition at intermediate shear rates.
Discussion
Previous studies have established that the procoagulant properties of platelets are due, in part, to their capacity to bind activated coagulation factors and to accelerate the conversion of the zymogen forms of Factors X and II (prothrombin) to their active enzymes (6) (7) (8) (39) (40) (41) (42) (43) (44) . Impairment ofthese properties may result in a mild bleeding disorder (Scott syndrome) (35) (36) (37) . In addition, a possible role for platelet glycoproteins has been implied by studies on patients with the Bernard-Soulier syndrome (45-47) (GPIb deficiency), and thrombasthenia (48-50) (GPIIb-IIIa deficiency). The above studies have, in general, been performed at relatively low shear conditions and in the absence of vascular surfaces where alternative mechanisms (such as tissue factor [51, 52] ) for activating the coagulation pathway could be important. A major purpose of this study was to evaluate the procoagulant properties of platelets on a de-endothelialized vascular surface exposed in vivo to blood from normal subjects and patients with platelet disorders at shear rates ranging from 50 to 2,600 s-'.
The present studies performed with normal non-anticoagulated blood clearly demonstrate the strong, and opposite, effect, of blood flow on platelet and fibrin deposition and suggest that, under the conditions utilized in the study, platelets influence fibrin formation at shear rates of 650-1,300 s-'. Evidence that platelets do, in fact, influence fibrin deposition in this intermediate shear range was obtained in patients with thrombocytopenia. At 650 s-', fibrin deposition on the subendothelium after a 5-min perfusion of the vessel segments was decreased in the four patients with the lowest adhesion values, and was normal in the six others (Table II) . Although the number of patients studied was small, the findings suggest that relatively few adherent platelets (in this study a surface coverage of 4% or more corresponding to platelet counts > 5,000/,4l) were sufficient to support normal levels of fibrin deposition on the subendothelium. In contrast to the findings at the shear rate of 650 s-', platelets appeared to be less important for fibrin deposition at 50 s-'. Thus, fibrin deposition was maximal at this shear rate, despite minimum values (5.3±0.5%) for platelet adhesion, and one patient with severe thrombocytopenia (platelet count 1,000/,ul) was found to have normal (89% surface coverage) fibrin deposition despite the virtual absence of platelets on the subendothelium.
An inverse relationship between fibrin deposition and shear rate was observed at shear rates above 650 s'l. Thus, fibrin deposition decreased dramatically at 2,600 s-' despite much higher values of platelet adhesion and larger platelet thrombi than at lower shear conditions (Fig. 1) .
Studies performed in patients with functional platelet disorders at 650 s-' provide additional information on the specific properties of platelets that contribute to fibrin deposition at this shear rate. Decreased fibrin deposition was observed in the patient with Scott syndrome with impaired platelet procoagulant activities (see Methods) despite normal (in fact, slightly increased) values of platelet adhesion. The findings in the present study demonstrate that the platelet properties deficient in Scott syndrome are important in promoting fibrin deposition on a vascular surface under flow conditions comparable to those in large arteries. In addition, studies performed at varying shear rates in this patient further support the relative unimportance ofplatelets at low shear rates (normal values for fibrin deposition at 50 s-'), and demonstrate that the defect in fibrin deposition in Scott syndrome is strongly dependent on flow conditions throughout the entire range of shear rates studied (Fig. 5) . The findings in patients with thrombasthenia, whose platelets are deficient in GPIIb-IIIa, were in marked contrast to those with Scott syndrome. In three patients with this disorder, fibrin deposition was normal (in fact, somewhat increased) at 650 s-' despite the complete absence of platelet thrombi. The findings indicate that a monolayer of platelets (even those deficient in GPIIb-IIIa) is sufficient to promote the deposition offibrin on the subendothelium under the conditions studied. We also found an abnormality of fibrin deposition in the Bernard-Soulier syndrome, but of a somewhat different nature than in Scott syndrome. Unlike the latter, which was associated with reduced fibrin deposition on both the subendothelium and on platelets, only the latter was strikingly decreased in the Bernard-Soulier syndrome (Tables II  and III) . The marked reduction in fibrin associated with platelets could be due to an impaired binding of polymerizing fibrin to these platelets, as suggested by a recent report that the interaction of platelets with polymerizing fibrin (which is normal in thrombasthenia [53] ) is mediated by von Willebrand factor through a GPIb-dependent mechanism (54) . Other mechanisms pertaining to impaired binding of thrombin by Bernard-Soulier platelets (55), due to deficiencies ofGPIb and V (56) (57) (58) (59) are also possible. From the above observations, a plausible explanation for the various findings in this study must take into account the strong, and inverse, relationship of fibrin deposition with shear rate, the relative lack of a platelet requirement at low shear rates (where fibrin deposition can occur despite little or no platelet deposition), the progressive decrease in fibrin deposition at shear rates > 650 s-' (despite increasing platelet deposition), and the findings in patients with various types of platelet disorders. A likely explanation is that fibrin deposition on the surface is influenced (as indicated above) by procoagulant properties of both the subendothelial surface and the deposited platelets, and by Theological factors which determine the concentrations of activated coagulation proteins either in the boundary layer or immobilized by surface binding to platelets on the subendothelial surface. As discussed extensively by Leonard (60) , the concentration ofproteins activated, but not bound, at the surface through the coagulation mechanism will be strongly influenced by flow factors, and the net concentration will be determined both by the biochemical reactions producing activated coagulation factors and by convective-diffusive factors that serve to moderate the concentrations of unactivated and activated coagulation proteins. In general, because the boundary layer for activated species (products) is diluted as wall shear rate increases, it follows that the effective concentration of activated coagulation factors in the boundary layer will also decrease. This might explain the inverse relationship between fibrin deposition and shear rate observed with normal blood (Figs. 1 and 2) . In that platelets have been shown to bind activated coagulation factors, such as Factor Xa (43, 44) and Va (61, 62) , to their surface, the presence ofadherent platelets on the subendothelium could, with increasing shear rates, serve to maintain activated coagulation proteins in the boundary layer at a concentration that would otherwise be reduced through convective diffusion in their absence. Thus, at low shear rates (50 s-1), the concentration of activated coagulation factors in the boundary layer might be sufficient to support fibrin deposition despite the absence of platelets, whereas, at very high shear rates (2,600 s-' and above), even the presence ofplatelets is insufficient to maintain the required concentration. The shear-dependent defect offibrin formation in a patient with Scott syndrome, a disorder in which impaired binding ofFactor Xa has been previously demonstrated (36), is consistent with such a theory.
In addition to measuring fibrin deposition on the vessel surface, we also measured FPA levels in the blood at the termination of the run. With blood from normal subjects, there was a good correlation between fibrin deposition on the surface and blood FPA levels; both decreased in parallel with increasing shear rate (Fig. 2) . This was also the case in the patient with Scott syndrome. Decreased fibrin deposition was associated with decreased FPA levels, the latter becoming particularly striking at 650 s-' with the longer (10 min) perfusion time during which the subendothelial surface became saturated (73% coverage) with her platelets (Table III) . In contrast, FPA levels were consistently normal in patients with thrombocytopenia, even when (as in patients with platelet adheson values < 4%) surface coverage with fibrin was markedly reduced (Tables II and III) . Several explanations are consistent with the above findings. First, the generation ofblood FPA levels is dependent primarily on the surface and flow conditions, regardless of the presence of platelets. This is not inconsistent with previous findings demonstrating the procoagulant properties of platelets in systems utilizing washed platelets and purified coagulation proteins (6-8, 61, 62) . Rather, it demonstrates the complexity introduced by the presence of a vessel surface which, itself, has procoagulant properties. A second conclusion is that a vessel surface which has become saturated with platelets whose defect is that observed in Scott syndrome has an impaired ability to generate FPA. Finally, the major role of platelets in normal blood exposed to a procoagulant vessel surface may be to localize specifically the deposition of fibrin on the vascular surface, as discussed above.
The findings in the present study emphasize the importance ofconsidering flow in evaluating the properties ofplatelets which contribute to the localization offibrin on a potentially coagulant vessel surface. These considerations are important in view of evidence, such as the results from recent studies utilizing fibrinolytic agents in patients with acute myocardial infarction (63) , that fibrin is a major component in some types of arterial thrombi. We realize that the stimulus for activating the coagulation mechanism provided by a ruptured atherosclerotic plaque may not be indentical to that provided in our ex vivo model utilizing a de-endothelialized vessel that has been stored for varying periods of time prior to use. Fibrin deposition has not been observed in vessels ballooned in vivo where blood flow is allowed to reestablish normally (22, (64) (65) (66) . However, even under these conditions, the deposition of fibrin appears to be influenced by both the local flow conditions and vascular factors. For example, ifblood flow in the vessel is reduced by constriction to the ballooned area, fibrin deposition can be readily observed (22) . In addition, fibrin deposition occurs more readily after reinjury ofthe neointimal surface (67-69) and this could be the case for vessels injured by atherosclerosis, or at sites where hemodynamic forces would be expected to cause repeated vessel injury (70) as well. Thus, the vessels used in our studies, perhaps injured during 7-28 d of storage, could more closely approximate the thrombogenicity of diseased vessels than those exposed to blood after a single balloon cathether injury in vivo. If our model has clinical validity, the results of our study could have therapeutic implications in developing antiplatelet agents which would inhibit fibrin deposition. Thus, fibrin deposition might be reduced on a surface covered with platelets equivalent to those found in Scott syndrome. This might be particularly relevant in vessels such as the major epicardial arteries, where shear rates in the range of 200-800 s-' are characteristically observed (17) . In addition, as seen in the patient with Scott syndrome (Tables  II and III) , by inhibiting thrombin formation, the size of the platelet thrombi which form over the adherent platelets would also be decreased. Thus, by inhibiting both fibrin formation and the size of platelet thrombi, a strategy designed to inhibit platelet procoagulant activity could be potentially useful in preventing thrombosis in clinically important blood vessels.
